← Evidence map

ReviewDrug safety2026

Drug Brand Switching: A Regulatory Perspective.

Ping Siu Kee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42821031